CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Cell and Gene Therapy

NEO Clinic Tokyo has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top Cell and Gene Therapy Company in Japan – 2025,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Yasuki Hijikata, Medical Doctor.

NEO Clinic Tokyo
Personalizing Cancer Care and Restoring the Human Spirit

NEO Clinic Tokyo

Yasuki Hijikata, NEO Clinic Tokyo | Life Science Review | Top Cell and Gene Therapy Company in APACYasuki Hijikata, Medical Doctor
In the heart of Tokyo, a quiet revolution in oncology and preventive medicine has been underway. NEO Clinic Tokyo leads this transformation, where cancer care moves beyond halting tumor metastasis to embrace the full complexity of each patient’s biology. Integrating state-of-the-art genomic profiling, next-generation immunotherapies, and regenerative techniques, the clinic delivers a personalized model of care that blends science with hospitality, offering a glimpse into the future of precision healthcare.

Setting this model apart is the advanced technology it employs and the belief that medicine must move beyond one-size-fits-all cancer treatments.

“Now that unprecedented advances in analytical technology have made it possible to analyze cancer genomes, we attempt to provide treatment based on differences in genomic abnormalities,” says Yasuki Hijikata, medical doctor.

This philosophy underpins every aspect of patient engagement, from initial consultation through follow -up, ensuring each individual feels heard, understood and supported.

The Limits of Standard Therapy and the Genomic Answer

Traditional cancer therapies, guided by histopathological analysis, often miss the biological diversity within cancers classified as the same type. Cancer is not a singular disease but an accumulation of genomic abnormalities unique to each patient.

Recognizing this, NEO Clinic Tokyo uses whole-genome and exome sequencing—not just targeted gene panels—to design immunotherapies tailored to each tumor’s unique genetic fingerprint. While standard panels yield actionable results in only about 10 percent of cases, broader sequencing uncovers mutations even in non-canonical regions, expanding therapeutic possibilities.

Treatments include neoantigen vaccines, immune checkpoint inhibitors, and immune modulators, carefully selected based on exhaustive clinical trial data and AI-assisted analysis. NEO’s approach does not discard conventional therapy—it enhances it, bringing precision to the forefront.

We hope that patients who are tired of treatment, or even their families who are tired of caring, will come to our clinic to refresh and heal their minds through advanced treatment and Japanese hospitality

Activating, Restoring and Controlling Immune Response

NEO Clinic Tokyo’s cancer treatment philosophy rests on three pillars; immune modulation, immune enhancement and restoration, and immunosuppression control. This triad tackles one of oncology’s greatest challenges—the immunosuppressive environment tumors create.

Each patient’s immune microenvironment is mapped via comprehensive blood tests and tumor RNA profiling, tracking biomarkers like CRP, IL-6 and albumin, key indicators of inflammation and immune status. When immune checkpoints are upregulated, targeted inhibitors are prescribed. When regulatory T cells dominate, low-dose metronomic chemotherapy or kinase inhibitors tip the balance back toward immune activation.

“By quantifying key biomarkers and characterizing the tumor milieu, we seek to recondition the immune landscape, dismantling suppression, restoring immune vigor, and fine-tuning modulation,” says Dr. Hijikata. This data-driven personalization is a far cry from the trial-and-error of traditional treatment regimens. It transforms immunotherapy from a shot in the dark into a precision-engineered intervention.

Regeneration and Rejuvenation: Medicine for the Future

NEO Clinic Tokyo is focused on treating cancer while also aiming to prevent it. Risks for lifestyle-related diseases are assessed through predictive genome testing and early intervention strategies are formulated. This includes precision nutritional counseling, immune-boosting exercise, and targeted therapies such as cytokine treatment, DNA repair agents and stem cell-derived exosomes.

Its proprietary StemSup therapy uses mesenchymal stem cells derived from adipose tissue, dental pulp, and umbilical cord blood. These cells secrete exosomes that promote collagen synthesis, tissue repair, and organ rejuvenation. The implications go beyond aesthetics. This technology holds the key to mitigating chemotherapy-induced damage, restoring cellular function, and potentially slowing age-related decline across multiple organ systems.

  • Now that unprecedented advances in analytical technology have made it possible to analyze cancer genomes, we attempt to provide treatment based on differences in genomic abnormalities


Also leveraged is cytokine therapy for its regenerative and anti-inflammatory properties. Pro-inflammatory cytokines are suppressed, while growth factors stimulate cell proliferation and tissue healing. This dual use of immunomodulation further underscores NEO’s integrative approach.

Healing as a Human Experience

It Nagoya branch stands out as a serene, almost sanctuary-like environment designed to optimize treatment by holistically nurturing the body and mind. Medical care merges seamlessly with elements of relaxation and tranquility, alleviating the physical and emotional exhaustion patients face.

Treatments are administered in private, well-appointed rooms that overlook a historic Japanese garden, where the subtle play of seasons and the meditative arrangement of nature offer visual solace. Patients are never alone; they are attended by dedicated caregivers and soothed by therapeutic music in soundproof therapy rooms, cultivating a personal and peaceful atmosphere.

The branch also houses a medical fitness center designed to guide patients through immune-boosting, low-impact exercises created by specialists to enhance physiological resilience during treatment. A precision nutrition café offers gourmet, medically aligned meals that cater to the dietary needs of patients and their families, turning nourishment into an act of care.

The integration of traditional therapies such as Japanese Kampo medicine and other Chinese and Indian practices, along with psychotherapy, naturopathy, exercise therapy and music therapy, further supports a holistic journey. NEO Clinic Tokyo selects and applies these approaches comprehensively and systematically to provide the most appropriate individualized treatment. To expand this holistic model, the firm plans to incorporate Japanese Kobudo, the traditional martial art long used in spiritual study.

The emphasis on holistic well-being is essential to the firm’s long-term vision to extend lifespans and support mental and emotional resilience along with physical healing.

A Model for Precision at Scale

Despite the sophistication of its treatments, NEO Clinic Tokyo is also mindful of accessibility. By maintaining its Ministry-Certified Cell Processing Center and minimizing outsourcing, it reduces overhead and delivers fresh regenerative products quickly. Seminars are hosted to educate physicians and patients on genomic medicine—a field still unfamiliar to many in the broader medical community.

NEO Clinic Tokyo’s long-term objectives are even more strategically ambitious. It is working toward developing an AI-based protocol informed by its accumulated treatment data that could suggest optimal therapies based on thousands of prior patient trajectories, reducing time to treatment and increasing precision. This vision of scalable precision medicine could mark a significant step in making advanced treatments more accessible to patients everywhere. Its track record already reflects this commitment. A number of its patients with late-stage, treatment-resistant cancers achieved complete remission through a blend of standard therapy and personalized immunotherapy.

“We hope that patients who are tired of treatment, or even their families who are tired of caring, will come to our clinic to refresh and heal their minds through advanced treatment and Japanese hospitality,” Dr. Hijikata says.

At a time when medical innovation can feel cold or mechanical, NEO Clinic Tokyo offers an alternative where cutting-edge therapies coexist with deep human compassion. By blending genomics, immunology, regenerative medicine, and ancient healing wisdom into a unified model of care, it is doing more than treating cancer—it is reshaping what it means to heal.

NEO Clinic Tokyo stands as a pioneering example, pointing the way for a future where personalization and compassion are inseparable companions in the journey toward healing.

Cell and Gene Therapy Info

Q1

What distinguishes Neo Clinic Tokyo among Top Cell and Gene Therapy Companies?

Neo Clinic Tokyo has earned recognition among Top Cell and Gene Therapy Companies through its specialized focus on regenerative medicine, stem cell therapies and personalized anti-aging treatments. The clinic combines advanced cellular therapies with individualized medical planning designed to support wellness, recovery and regenerative health management. Its physician-led approach emphasizes scientifically informed treatment protocols tailored to each patient’s condition and long-term health objectives. Neo Clinic Tokyo also differentiates itself through its integration of regenerative medicine with preventive healthcare and aesthetic-focused therapeutic applications. (lifesciencesreview.com )

Q2

How does Neo Clinic Tokyo approach regenerative and cellular therapies?

Personalized regenerative medicine forms the foundation of the clinic’s treatment philosophy. Unlike some Cell and Gene Therapy Companies that focus primarily on laboratory development or manufacturing, Neo Clinic Tokyo applies regenerative medicine directly within patient-centered therapeutic programs. Its services involve stem cell-based therapies, immune cell treatments and regenerative procedures designed to support tissue repair and overall wellness. The clinic also conducts detailed medical evaluations before treatment selection, helping align regenerative therapies with individual patient health profiles and therapeutic goals. (lifesciencesreview.com )

Q3

Why is Neo Clinic Tokyo relevant to modern regenerative healthcare trends?

Interest in regenerative medicine and longevity-focused healthcare continues to grow as patients seek therapies that support natural healing and preventive wellness strategies. Neo Clinic Tokyo addresses this demand through regenerative medicine programs that combine cellular science with individualized healthcare planning. Among Cell and Gene Therapy Companies, the clinic stands out for integrating regenerative therapies into broader wellness and anti-aging care models rather than limiting applications to isolated clinical procedures. Its approach also reflects increasing healthcare interest in biologic therapies designed to support long-term tissue health and patient well-being. (lifesciencesreview.com )

Q4

What role does innovation play in Neo Clinic Tokyo’s treatment strategy?

Scientific advancement and regenerative technology remain central to Neo Clinic Tokyo’s clinical identity. The clinic incorporates evolving stem cell and immune cell technologies into treatment programs designed to support regenerative wellness and restorative healthcare applications. Its therapeutic model aligns with broader innovation trends across regenerative medicine involving cellular therapies, biologic treatments and personalized healthcare planning. Cell and Gene Therapy Companies often differentiate themselves through treatment adaptability and regenerative expertise, and Neo Clinic Tokyo reinforces that distinction through continuous engagement with modern regenerative medicine developments. (lifesciencesreview.com )

Q5

How does Neo Clinic Tokyo support patients throughout treatment?

Comprehensive patient care plays an important role in the clinic’s service model. Neo Clinic Tokyo supports patients through medical consultation, diagnostic evaluation, treatment planning and follow-up monitoring designed around individualized regenerative health objectives. Its physician-led structure helps ensure that treatment recommendations remain aligned with patient needs, safety considerations and long-term wellness goals. Among Cell and Gene Therapy Companies, the clinic distinguishes itself through personalized communication and medically supervised regenerative care designed to support a more informed and comfortable patient experience. (lifesciencesreview.com )

Q6

Why has Neo Clinic Tokyo gained visibility in regenerative medicine discussions?

Industry attention toward regenerative wellness and biologic healthcare innovation has contributed to Neo Clinic Tokyo’s growing visibility within regenerative medicine. The clinic continues to strengthen its reputation through personalized stem cell therapies, wellness-focused regenerative care and physician-guided treatment planning. Its integration of regenerative medicine principles into preventive and restorative healthcare reflects broader healthcare interest in cellular therapies and biologic treatment applications. This combination of regenerative expertise, personalized care and wellness-oriented treatment strategies supports Neo Clinic Tokyo’s standing among Cell and Gene Therapy Companies. (lifesciencesreview.com )

Top Cell and Gene Therapy Company in Japan – 2025
Current Issue

Company : NEO Clinic Tokyo

Management
Yasuki Hijikata, Medical Doctor

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/neo-clinic-tokyo